◎文╱傅郁螢
治療藥物選擇（續）
台灣常見的 C 型肝炎病毒為基因型1b及基因型2，依台灣目前已上市藥品，建議C型肝炎的治療用藥及肝臟移植後C型肝炎復發之治療用藥建議如表一及表二所列。
（待續）
參考資料
1. Recommendations for Testing, Managing, and Treating Hepatitis C. Joint panel from the American Association of the Study of Liver Diseases and the Infectious Diseases Society of America. http://www.hcvguidelines.org/ (Accessed on July 08, 2016. Changes made September 27, 2016).
2. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distributionof the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–S57.
3. Sanjiv Chopra, MD, MACP, Paul J Pockros. Overview of the management of chronic hepatitis C virus infection.UpToDate [database on the Internet].Wolters Kluwer, Alphen aan den Rijn, the Netherlands. [cited 2017JAN. 17]. Available from: http://www.uptodate.com.
（本文作者為三軍總醫院臨床藥學部藥師）
回首頁 |
